Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Hepatitis C virus infection
MP Manns, M Buti, ED Gane, JM Pawlotsky… - Nature reviews Disease …, 2017 - nature.com
Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage,
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …
[PDF][PDF] Course and outcome of hepatitis C
JH Hoofnagle - Hepatology, 2002 - Wiley Online Library
The hepatitis C virus (HCV) is a small enveloped RNA virus belonging to the family
flaviviridae and genus hepacivirus. The HCV RNA genome is 9,600 nucleotides in length …
flaviviridae and genus hepacivirus. The HCV RNA genome is 9,600 nucleotides in length …
Internal ribosome entry sites in eukaryotic mRNA molecules
CUT Hellen, P Sarnow - Genes & development, 2001 - genesdev.cshlp.org
Initiation of translation of most eukaryotic mRNAs commences with 5 end–dependent
recruitment of 40S ribosomal subunits to the mRNA. The 40S subunit carrying the initiator …
recruitment of 40S ribosomal subunits to the mRNA. The 40S subunit carrying the initiator …
The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control
J Bukh - Journal of hepatology, 2016 - Elsevier
The discovery of hepatitis C virus (HCV) in 1989 permitted basic research to unravel critical
components of a complex life cycle for this important human pathogen. HCV is a highly …
components of a complex life cycle for this important human pathogen. HCV is a highly …
Thermodynamically Stable RNA Three-Way Junction for Constructing Multifunctional Nanoparticles for Delivery of Therapeutics 1
D Shu, Y Shu, F Haque, S Abdelmawla… - RNA Nanotechnology …, 2022 - taylorfrancis.com
RNA nanoparticles have applications in the treatment of cancers and viral infection;
however, the instability of RNA nanoparticles has hindered their applications for therapeutic …
however, the instability of RNA nanoparticles has hindered their applications for therapeutic …
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion
P Gastaminza, G Cheng, S Wieland, J Zhong… - Journal of …, 2008 - journals.asm.org
Intracellular infectious hepatitis C virus (HCV) particles display a distinctly higher buoyant
density than do secreted virus particles, suggesting that the characteristic low density of …
density than do secreted virus particles, suggesting that the characteristic low density of …
Hepatitis C Virus IRES RNA-Induced Changes in the Conformation of the 40S Ribosomal Subunit
Initiation of protein synthesis in eukaryotes requires recruitment of the 40 S ribosomal
subunit to the messenger RNA (mRNA). In most cases, this depends on recognition of a …
subunit to the messenger RNA (mRNA). In most cases, this depends on recognition of a …
Mechanism of ribosome recruitment by hepatitis C IRES RNA
Many viruses and certain cellular mRNAs initiate protein synthesis from a highly structured
RNA sequence in the 5′ untranslated region, called the internal ribosome entry site (IRES) …
RNA sequence in the 5′ untranslated region, called the internal ribosome entry site (IRES) …
Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122
RK Jangra, MK Yi, SM Lemon - Journal of virology, 2010 - journals.asm.org
ABSTRACT miR-122 is a liver-specific microRNA that positively regulates hepatitis C virus
(HCV) RNA abundance and is essential for production of infectious HCV. Using a genetic …
(HCV) RNA abundance and is essential for production of infectious HCV. Using a genetic …
Genetic epidemiology of hepatitis C virus throughout Egypt
Hepatitis C virus (HCV) infection is a major health problem in Egypt, where the
seroprevalence is 10–20-fold higher than that in the United States. To characterize the HCV …
seroprevalence is 10–20-fold higher than that in the United States. To characterize the HCV …